Fetal stem cells

被引:120
作者
O'Donoghue, K
Fisk, NM
机构
[1] Univ London Imperial Coll Sci Technol & Med, Expt Fetal Med Grp, Inst Reprod & Dev Biol, London W12 0NN, England
[2] Queen Charlottes & Chelsea Hosp, Ctr Fetal Care, London W12 0NN, England
关键词
fetal blood progenitors; fetal bone marrow; fetal liver; haemopoietic; mesenchymal;
D O I
10.1016/j.bpobgyn.2004.06.010
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Fetal stem cells can be isolated from fetal blood and bone marrow as well as from other fetal tissues, including liver and kidney. Fetal blood is a rich source of haemopoietic stem cells (HSC), which proliferate more rapidly than those in cord blood or adult bone marrow. First trimester fetal blood also contains a population of non-haemopoietic mesenchymal stem cells (MSC), which support haemopoiesis and can differentiate along multiple lineages. In terms of eventual downstream application, both fetal HSC and MSC have advantages over their adult counterparts, including better intrinsic homing and engraftment, greater multipotentiality and lower immunogenicity. Fetal stem cells are less ethically contentious than embryonic stem cells and their differentiation potential appears greater than adult stem cells. Fetal stem cells represent powerful tools for exploring many aspects of cell biology and hold considerable promise as therapeutic tools for cell transplantation and ex vivo gene therapy.
引用
收藏
页码:853 / 875
页数:23
相关论文
共 101 条
[51]   VARIATIONS IN THE STROMAL CELL-POPULATION OF HUMAN-BONE MARROW DURING AGING [J].
METS, T ;
VERDONK, G .
MECHANISMS OF AGEING AND DEVELOPMENT, 1981, 15 (01) :41-49
[52]   Which stem cells should be used for transplantation? [J].
Michejda, M .
FETAL DIAGNOSIS AND THERAPY, 2004, 19 (01) :2-8
[53]  
Minasi MG, 2002, DEVELOPMENT, V129, P2773
[54]   Pregnancy and microchimerism in autoimmune disease: Protector or insurgent? [J].
Nelson, JL .
ARTHRITIS AND RHEUMATISM, 2002, 46 (02) :291-297
[55]   Unique differentiation programs of human fetal liver stem cells shown both in vitro and in vivo in NOD/SCID mice [J].
Nicolini, FE ;
Holyoake, TL ;
Cashman, JD ;
Chu, PPY ;
Lambie, K ;
Eaves, CJ .
BLOOD, 1999, 94 (08) :2686-2695
[56]   Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy [J].
O'Donoghue, K ;
Chan, J ;
de la Fuente, J ;
Kennea, N ;
Sandison, A ;
Anderson, JR ;
Roberts, IAG ;
Fisk, NM .
LANCET, 2004, 364 (9429) :179-182
[57]   Identification of fetal mesenchymal stem cells in maternal blood: implications for non-invasive prenatal diagnosis [J].
O'Donoghue, K ;
Choolani, M ;
Chan, J ;
de la Fuente, J ;
Kumar, S ;
Campagnoli, C ;
Bennett, PR ;
Roberts, IAG ;
Fisk, NM .
MOLECULAR HUMAN REPRODUCTION, 2003, 9 (08) :497-502
[58]   Changing phenotypes of hematopoietic stem cells [J].
Ogawa, M .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) :3-6
[59]   Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease [J].
Ordemann, R ;
Hutchinson, R ;
Friedman, J ;
Burakoff, SJ ;
Reddy, P ;
Duffner, U ;
Braun, TM ;
Liu, C ;
Teshima, T ;
Ferrara, JLM .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (09) :1249-1256
[60]   THE RISKS OF EARLY CORDOCENTESIS (12-21 WEEKS) - ANALYSIS OF 500 PROCEDURES [J].
ORLANDI, F ;
DAMIANI, G ;
JAKIL, C ;
LAURICELLA, S ;
BERTOLINO, O ;
MAGGIO, A .
PRENATAL DIAGNOSIS, 1990, 10 (07) :425-428